References
- Pollack M, Pseudomonas aeruginosa. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone Inc, 1990; 1673–91.
- Reed RK, Larter WE, Sieber OF, et al. Peripheral nodular lesions in pseudomonas sepsis: the importance of incision and drainage. J Pediatr 1976; 88: 977–9.
- Picou KA, Jarrat MT. Persistent subcutaneous abscesses following Pseudomonas sepsis. Arch Dermatol 1979; 115: 459–60.
- Schlossberg D. Multiple erythematous nodules as a man ifestation of Pseudomonas aeruginosa septicemia. Arch Dermatol 1980; 116: 446–7.
- Bagel J, Grossman ME. Subcutaneous nodules in pseudomonas sepsis. Am J Med 1986; 80: 528–9.
- Ho JL, Barza M. Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection. Antimicrob Agents Chemother 1987; 31: 485–91.
- Milatovic D, Braveny I. Development of resistance during antibiotic therapy. Eur J Clin Microbiol 1987; 6: 234–44.
- Neu HC. Synergy and antagonism of combinations with quinolones. Eur J Clin Microbiol Infect Dis 1991; 10: 255–61.
- Meyer RD, Liu S. Synergy studies in vitro of the effect of ciprofloxacin and selected beta-lactam agents and aminoglycosides upon multidrug-resistant Pseudomonas aeruginosa. Rev Infect Dis 1989; 11 (Suppl 5): 1037–8.
- Bryant RE, Mazza JA. Effect of the abscess environment on the antimicrobial activity of ciprofloxacin. Am J Med 1989; 87 (Suppl 5A): 23–7.
- Huminer D, Siegman-Igra Y, Morduchowicz G, Pitlik SD. Ecthyma gangrenosum without bacteremia. Report of six cases and review of the literature. Arch Intern Med 1987; 147: 299–301.